CRISPR Therapeutics Appoints Samarth Kulkarni, Ph.D. as President, Expanding Role Beyond Chief Business Officer … – Yahoo Finance
NormanObserver.com |
CRISPR Therapeutics Appoints Samarth Kulkarni, Ph.D. as President, Expanding Role Beyond Chief Business Officer …
Yahoo Finance BASEL, Switzerland and CAMBRIDGE, Mass., May 04, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics (CRSP), a biopharmaceutical company focused on developing transformative gene-based therapeutics for patients with serious diseases, has … MPEG LA invites CRISPR-Cas9 patents to be pooled in a one-stop license Crispr Therapeutics AG (CRSP) Insider Sells $363,102.42 in Stock … Insider Selling: Crispr Therapeutics AG (CRSP) Insider Sells $91861.56 in Stock |
